Henry Schein Inc
$ 72.88
1.69%
03 Dec - close price
- Market Cap 8,838,041,000 USD
- Current Price $ 72.88
- High / Low $ 73.15 / 72.04
- Stock P/E 22.63
- Book Value 28.35
- EPS 3.22
- Next Earning Report 2026-02-18
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.08 %
- 52 Week High 82.49
- 52 Week Low 60.56
About
Henry Schein, Inc. (HSIC) is a prominent global leader in the provision of health care products and services, with a strong focus on the dental, medical, and veterinary sectors. Operating in more than 32 countries, the company harnesses its robust distribution network to deliver a comprehensive array of essential products and innovative technologies to health care professionals. Committed to improving the efficiency and effectiveness of health care delivery, Henry Schein is recognized as a trusted partner for practitioners and organizations worldwide, positioning itself at the intersection of healthcare, technology, and customer service.
Analyst Target Price
$77.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-13 | 2023-08-07 | 2023-05-09 | 2023-02-16 |
| Reported EPS | 1.38 | 1.1 | 1.15 | 1.19 | 1.22 | 1.23 | 1.1 | 0.66 | 1.32 | 1.31 | 1.21 | 1.21 |
| Estimated EPS | 1.28 | 1.19 | 1.1101 | 1.2089 | 1.17 | 1.22 | 1.01 | 0.69 | 1.32 | 1.28 | 1.23 | 1.21 |
| Surprise | 0.1 | -0.09 | 0.0399 | -0.0189 | 0.05 | 0.01 | 0.09 | -0.03 | 0 | 0.03 | -0.02 | 0 |
| Surprise Percentage | 7.8125% | -7.563% | 3.5943% | -1.5634% | 4.2735% | 0.8197% | 8.9109% | -4.3478% | 0% | 2.3438% | -1.626% | 0% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-18 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.3 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HSIC
2025-12-04 06:27:25
Henry Schein (HSIC) has secured exclusive U.S. distribution rights for vVARDIS's drill-free Curodont Repair Fluoride Plus product, expanding its role in preventive oral healthcare. This move, alongside advancements like VideaHealth’s Detect AI, supports Henry Schein's strategy to shift towards higher-margin specialties and digital solutions. Despite these growth initiatives, investors should remain aware of ongoing price competition risks in core dental supplies.
2025-12-04 06:12:47
Henry Schein has secured exclusive U.S. distribution rights for vVARDIS's drill-free Curodont Repair Fluoride Plus treatment, effective January 1, 2026. This move aligns with Henry Schein's strategy to expand into higher-margin specialties and digital solutions, augmenting its existing distribution business. While this could modestly support long-term growth, investors should consider ongoing competitive pricing pressures and the need for execution on cost savings in the near term.
2025-12-03 15:06:46
Henry Schein, Inc. announced an expansion of its agreement with vVARDIS, granting Henry Schein exclusive U.S. distribution rights for the Curodont Repair Fluoride Plus product across all dental market segments, effective January 1, 2026. This expansion broadens a previous agreement and will cover general dentistry, orthodontics, and pediatric dentistry nationwide. The Curodont product is a drill- and needle-free solution for early-stage cavities, addressing a significant unmet need in oral healthcare.
2025-12-03 12:56:00
Henry Schein Canada has successfully reduced disability leave claims and improved employee engagement through its comprehensive wellness program. The program, launched in 2023, focuses on five pillars: mental, physical, financial, social, and work-life balance, and has achieved a 90% employee approval rating. Investments in mental health initiatives, including wellness champions and leadership training, have also resulted in a significant return on investment for the company.
2025-12-02 22:06:56
Henry Schein Inc. announced an expanded agreement with vVARDIS to become the exclusive U.S. distributor of the Curodont Repair Fluoride Plus product across all dental market segments, effective January 1, 2026. This expansion builds on a previous agreement and extends Henry Schein's distribution rights to general dentistry, orthodontics, and pediatric dentistry practices nationwide. Curodont is a drill-free caries treatment for early-stage cavities, and this partnership aims to make it more accessible to the entire U.S. dental community given its success in reaching over 10% of U.S. dental offices.
2025-12-02 15:21:43
Henry Schein, Inc. (HSIC) has expanded its partnership with vVARDIS, gaining exclusive U.S. distribution rights for the Curodont Repair Fluoride Plus product starting January 1, 2026. This move is expected to bolster HSIC's Dental business and maintain positive stock momentum, building on previous strategic collaborations. The drill-free Curodont product addresses early-stage cavities, tapping into a significant market opportunity and aligning with the company's commitment to advancing oral health.
